Publication | Closed Access

Safety and efficacy of the HIV-1 attachment inhibitor prodrug BMS-663068 in treatment-experienced individuals: 24 week results of AI438011, a phase 2b, randomised controlled trial

Treatment And PreventionPhase 2BPharmacologyClinical TrialsAntiviral TherapyPharmacotherapyTreatment-experienced IndividualsHivAntiviral DrugMedicineWeek Results